We are live on ! Find out more
HSG

Helen Stephens Group Portfolio holdings

AUM $589M
1-Year Est. Return 18.4%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+18.4%
3 Year Est. Return
+49.55%
5 Year Est. Return
10 Year Est. Return
AUM
$337M
AUM Growth
+$8M
Cap. Flow
+$12.8M
Cap. Flow %
3.8%
Top 10 Hldgs %
67.39%
Holding
92
New
3
Increased
35
Reduced
42
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 1.97%
2 Energy 1.64%
3 Technology 1.55%
4 Consumer Staples 0.99%
5 Healthcare 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
76
SPDR Gold Trust
GLD
$131B
$245K 0.07%
1,011
ABBV icon
77
AbbVie
ABBV
$443B
$243K 0.07%
1,369
+61
+5% +$11.2K
LLY icon
78
Eli Lilly
LLY
$1.02T
$242K 0.07%
314
-76
-19% -$62.9K
SPSM icon
79
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$242K 0.07%
5,379
-76
-1% -$3.54K
NOBL icon
80
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$240K 0.07%
4,814
+52
+1% +$2.73K
GD icon
81
General Dynamics
GD
$104B
$238K 0.07%
904
+4
+0.4% +$1.15K
OKE icon
82
Oneok
OKE
$57.2B
$213K 0.06%
2,121
-219
-9% -$22.4K
IVW icon
83
iShares S&P 500 Growth ETF
IVW
$73.8B
$207K 0.06%
+2,041
New +$204K
DFGP icon
84
Dimensional Global Core Plus Fixed Income ETF
DFGP
$3.33B
$207K 0.06%
3,922
+227
+6% +$12.3K
DFSD
85
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.09B
$202K 0.06%
4,317
-1,344
-24% -$63.6K
SABR icon
86
Sabre
SABR
$731M
$159K 0.05%
43,534
ABUS icon
87
Arbutus Biopharma
ABUS
$857M
-13,000
Closed -$50K
ARDX icon
88
Ardelyx
ARDX
$1.22B
-11,000
Closed -$75.8K
ATKR icon
89
Atkore
ATKR
$2.46B
-2,573
Closed -$218K
ILCG icon
90
iShares Morningstar Growth ETF
ILCG
$3.11B
-11,640
Closed -$978K
SPDW icon
91
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.2B
-5,938
Closed -$223K
VEU icon
92
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
-3,469
Closed -$219K

Similar funds

Helen Stephens Group's Q4 2024 Portfolio in Review

As of Q4 2024, Helen Stephens Group held 92 positions worth $337M, up 2.4% from $329M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Helen Stephens Group deployed $12.8M of net new capital in Q4 2024, opening 3 new positions and adding to 35 existing holdings. Its largest new stake was JPMorgan Income ETF: 10,299 shares worth $470K.

By sector, the portfolio is most concentrated in Financials at 2% of assets, down from 2.1% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $26.3M trimmed.

  • Helen Stephens Group's largest Q4 2024 buy was JPMorgan Income ETF: 10,299 shares worth $470K.
  • Helen Stephens Group added most to Dimensional US Equity ETF in Q4 2024, an estimated $33.1M increase.
  • Helen Stephens Group's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $26.3M.
  • Helen Stephens Group fully exited iShares Morningstar Growth ETF in Q4 2024, selling an estimated $978K.
  • Helen Stephens Group's ten largest holdings make up 67% of its $337M portfolio in Q4 2024.
  • Helen Stephens Group opened 3 new positions and closed 6 in Q4 2024.
  • Helen Stephens Group's portfolio value rose 2.4% quarter-over-quarter to $337M.

Based on Helen Stephens Group's 13F filing for Q4 2024, filed 15 Jan 2025.